Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2015, Article ID 610581, 4 pages
http://dx.doi.org/10.1155/2015/610581
Case Report

Neonatal Acute Megakaryoblastic Leukemia Presenting with Leukemia Cutis and Multiple Intracranial Lesions Successfully Treated with Unrelated Cord Blood Transplantation

1Department of Pediatrics, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Japan
2Department of Second Surgery, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Japan

Received 22 April 2015; Revised 18 June 2015; Accepted 18 June 2015

Academic Editor: Ray Lowenthal

Copyright © 2015 Hiroshi Tsujimoto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Sande, R. J. Arceci, and B. C. Lampkin, “Congenital and neonatal leukemia,” Seminars in Perinatology, vol. 23, no. 4, pp. 274–285, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. M. H. van der Linden, S. Creemers, and R. Pieters, “Diagnosis and management of neonatal leukaemia,” Seminars in Fetal and Neonatal Medicine, vol. 17, no. 4, pp. 192–195, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. R. P. S. Bajwa, R. Skinner, K. P. Windebank, and M. M. Reid, “Demographic study of leukaemia presenting within the first 3 months of life in the Northern Health Region of England,” Journal of Clinical Pathology, vol. 57, no. 2, pp. 186–188, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Orbach, S. Sarnacki, H. J. Brisse et al., “Neonatal cancer,” The Lancet Oncology, vol. 14, no. 13, pp. e609–e620, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Kudo, S. Kojima, K. Tabuchi et al., “Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese childhood AML cooperative study group,” Journal of Clinical Oncology, vol. 25, no. 34, pp. 5442–5447, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Bresters, A. C. W. Reus, A. J. P. Veerman, E. R. van Wering, A. van Der Does-van Den Berg, and G. J. L. Kaspers, “Congenital leukaemia: the Dutch experience and review of the literature,” British Journal of Haematology, vol. 117, no. 3, pp. 513–524, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Isaacs Jr., “Fetal and neonatal leukemia,” Journal of Pediatric Hematology and Oncology, vol. 25, no. 5, pp. 348–361, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Bernstein, N. Dastugue, O. A. Haas et al., “Nineteen cases of the t(1;22)(p13;q13) acute megakaryoblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group,” Leukemia, vol. 14, no. 1, pp. 216–218, 2000. View at Google Scholar
  9. H. van den Berg, A. H. N. Hopman, K. C. Kraakman, and D. de Jong, “Spontaneous remission in congenital leukemia is not related to (mosaic) trisomy 21: case presentation and literature review,” Pediatric Hematology and Oncology, vol. 21, no. 2, pp. 135–144, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Kawasaki, K. Isoyama, M. Eguchi et al., “Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group,” Blood, vol. 98, no. 13, pp. 3589–3594, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. U. Creutzig, M. Zimmermann, J.-P. Bourquin et al., “Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report,” Leukemia, vol. 26, no. 4, pp. 654–661, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Reinhardt, S. Diekamp, C. Langebrake et al., “Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment,” Leukemia, vol. 19, no. 8, pp. 1495–1496, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. O'Brien, X. Cao, S. Pounds et al., “Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421,” Leukemia, vol. 27, no. 3, pp. 731–734, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. S. E. Karol, E. Coustan-Smith, X. Cao et al., “Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy,” British Journal of Haematology, vol. 168, no. 1, pp. 94–101, 2015. View at Publisher · View at Google Scholar